Patents
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
07/2008
07/03/2008WO2008079055A1 1-hydroxy-hermatrane salts with oxy-, keto- and poly-carboxylic acids
07/03/2008WO2008078723A1 Antibacterial agent and bactericidal agent
07/03/2008WO2008078411A1 Pharmaceutical agent for prevention and/or treatment of inflammatory myopathy
07/03/2008WO2008078331A1 Medicinal formulation for the treatment for hepatitis c
07/03/2008WO2008077651A1 Pyrido(3,2-d)pyrimidines useful for treating viral infections
07/03/2008WO2008077650A1 Pyrido(3,2-d)pyrimidines useful for treating viral infections
07/03/2008WO2008077649A1 Pyrido(3,2-d)pyrimidines useful for treating viral infectons
07/03/2008WO2008077618A1 Use of xanthohumol and/or isoxanthohumol as an agent for preventing and/or combating liver diseases
07/03/2008WO2008077404A1 Substituted acetophenones useful as pde4 inhibitors
07/03/2008WO2008077251A1 Growth inhibition and elimination of methicillin-resistant staphylococcus aureus by lactic acid bacteria
07/03/2008WO2008077241A1 Phosphonated glycopeptide and lipoglycopeptide antibiotics and uses thereof for the prevention and treatment of bone and joint infections
07/03/2008WO2008077229A1 Growth inhibition of microorganisms by lactic acid bacteria
07/03/2008WO2008077188A1 Bicyclic pyrimidinones and uses thereof
07/03/2008WO2008060927A3 Hepatitis c virus inhibitors
07/03/2008WO2008060927A2 Hepatitis c virus inhibitors
07/03/2008WO2008014307A3 Inhibitors of undecaprenyl pyrophosphate synthase
07/03/2008US20080161907 Stent coated with a sustained-release drug delivery and method for use thereof
07/03/2008US20080161562 2-(6-Chloro-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl)-benzonitrile
07/03/2008US20080161405 Multivessel package containing polyol such as mannose
07/03/2008US20080161391 Novel curcumin analogues and uses thereof
07/03/2008US20080161376 Using antimycotic formulation containing propylene glycol, disodium edta, mineral oil, polyglyceryl-3-oleate, glyceryl monoisostearate, microcrystalline wax, silicon dioxide, methylparaben, propylparaben, butoconazole nitrate in water and sorbitol solution
07/03/2008US20080161351 Peroxisome proliferator-activated receptor (PPAR) delta modulators; inhibitors of inducible nitric oxide synthase (iNOS) or tumor necrosis factor (TNF); metabolic disorders, inflammatory diseases and cancer
07/03/2008US20080161350 Use of quinoline derivatives with anti-integrase effect and applications thereof
07/03/2008US20080161324 Screening for effective drug combinations; single stranded RNA, flaviviridae and/or hepatic viruses; reducing side effects
07/03/2008US20080161311 e.g. 2-(3,4-dichlorobenzyl)-9-hydroxy-3,4-dihydro-2H-pyrido[1,2-a]pyrazine-1,8-dione hydrochloride; AIDS, or as an anti-HIV agent; non-toxic, fewer side effects
07/03/2008US20080161310 (2S)-4,4-difluoro-1-(2-{[1-(2-pyrazinyl)piperidin-4-yl]amino}acetyl)-2-pyrrolidine carbonitrile; enzyme inhibitors; diabetes
07/03/2008US20080161302 Antifungal Agents
07/03/2008US20080161287 Bicyclic compound, production and use thereof
07/03/2008US20080161271 e.g. 9-Hydroxy-2-(2-methoxy-ethyl)-1,8-dioxo-1,8-dihydro-2H-pyrid[1,2-a]pyrazi ne-7-carboxylic acid 4-fluoro-banzylamide; Human T cell leukemia virus, Feline and Simian immunodeficiency virus inhibitor; side effects reduction
07/03/2008US20080161264 N-{3-[3-(3-Isopropyl-5-methyl-4H-1,2,4-triazol-4-yl)-exo-8-azabicyclo[3.2.1]oct-8-yl]-1-phenylpropyl}-4,4-difluorocyclohexanecarboxamide; with deuterium isotop; chemokine (C-C motif) CCR5 receptor antagonist; antiinflammatory agent, viricide; with other active ingredients; HIV, AIDS, multiple sclerosis
07/03/2008US20080161263 Fusion proteins of Mycobacterium tuberculosis
07/03/2008US20080161257 Oligonucleotide-Containing Pharmacological Compositions And Their Use
07/03/2008US20080161254 Hcv inhibitors
07/03/2008US20080161250 Topical treatment or prevention of ocular infections
07/03/2008US20080161249 Use of Novel Antibacterial Compounds
07/03/2008US20080161247 Synergistic composition for modulating activity of substrate analogs for NAD+, NADP+, NADH or NADPH dependent enzymes and process thereof
07/03/2008US20080161246 Cytochrome P450 Oxidase Inhibitors and Uses Thereof
07/03/2008US20080161236 Therapeutic nucleic acid-3'-conjugates
07/03/2008US20080160112 Pharmaceutical use of water-soluble fraction of graptopetalum
07/03/2008US20080160089 Vaccine delivery compositions and methods of use
07/03/2008US20080160074 three-dimensional synthetic and semi-synthetic compositions having biological activity, such as liposomes, beads or similar particles; anti-inflammatory, organ protective and immune regulatory effects
07/03/2008US20080160065 insert suitable for mammalian intravaginal, buccal, or intrarectal use; non-degradable hydrogel matrix
07/03/2008US20080160046 Equine herpes viruses (EHV) with immunomodulatory capacity; respiratory and neurological diseases
07/03/2008US20080160045 Vaccines Comprising Aluminum Adjuvants and Histidine
07/03/2008US20080160040 Using papillomavirus minor capsid protein as tool in generating neutralizing antibodies which prevent and treat papillomal infection
07/03/2008US20080160039 Pneumovirus NS proteins antagonize the interferon IFN response
07/03/2008US20080160033 Novel Screening Method
07/03/2008US20080160028 Phosphodiesterase-4 (PDE-4) inhibitors; for treating bronchial asthma, COPD, rheumatoid arthritis (RA), osteoarthritis, cystic fibrosis, Guillain-Barresyndrome, Crohn's disease, ulcerative colitis, psoriasis, atopic dermatitis, allergic eczemas
07/03/2008US20080160027 Chlamydia pneumoniae vaccine and methods for administering such a vaccine
07/03/2008US20080160005 Interleukin-6 suppressive agent
07/03/2008US20080159982 ethyl 2-(biphenyl-4-yl)-6-(tert-butoxycarbonylamino)-2-methoxy-8-(2-nitrophenylsulfonyl)-5,16-dioxo-1,2,3,5,6,7,10,11,13a,14,14a,15,16,16a-hexadecahydrocyclopropa[n]pyrrolo[2,1-c][1,4,8]triazacyclopentadecine-14a-carboxylate; viricide; synergistic with other active ingredients
07/03/2008CA2684165A1 Oligonucleotide-prolyethylene glycol compound
07/03/2008CA2673678A1 Phosphonated glycopeptide and lipoglycopeptide antibiotics and uses thereof for the prevention and treatment of bone and joint infections
07/03/2008CA2673543A1 Multivalent pneumococcal polysaccharide-protein conjugate composition
07/03/2008CA2673466A1 Substituted tetracycline compounds
07/03/2008CA2673370A1 Substituted acetophenones useful as pde4 inhibitors
07/03/2008CA2673183A1 Bicyclic pyrimidinones and uses thereof
07/03/2008CA2673070A1 Method and system for enhancing self-treatment of onychomycosis
07/03/2008CA2672640A1 Growth inhibition of microorganisms by lactic acid bacteria
07/03/2008CA2672518A1 Organic compounds and their uses
07/03/2008CA2672155A1 Use of xanthohumol or isoxanthohumol as an active substance for the prevention and/or control of liver diseases
07/03/2008CA2670763A1 4-(1-amino-ethyl)-cyclohexylamine derivatives
07/03/2008CA2664118A1 Protease inhibitors
07/02/2008EP1939291A2 Inhibitor oligonucleotides and their use for specific repression of a gene
07/02/2008EP1939290A2 Gene expression control
07/02/2008EP1939278A1 Method for production of t cell population
07/02/2008EP1939213A1 Novel compounds as inhibitors of hepatitis C virus NS3 serine protease
07/02/2008EP1939203A2 Inhibitors of human phosphatidyl-inositol 3-kinase delta isoform
07/02/2008EP1939202A1 Novel adenine compound
07/02/2008EP1939201A1 Novel adenine compound
07/02/2008EP1939200A1 Novel adenine compound
07/02/2008EP1939199A1 Novel adenine compound
07/02/2008EP1939198A1 Novel adenine compound
07/02/2008EP1938841A2 Synergistic composition for modulating activity of substrate analogs for NAD+, NADP+, NADH+ or NADPH dependent enzymes and process thereof
07/02/2008EP1938826A1 Use of nocardia rubra cell wall skeleton to produce medicaments for resisting human papilloma virus hpv
07/02/2008EP1938824A1 Medicine, food and drink or feed containing sphingomyelin
07/02/2008EP1937825A2 Modified 4'-nucleosides as antiviral agents
07/02/2008EP1937710A1 Kinin b1 receptor peptide agonists and uses thereof
07/02/2008EP1937678A1 Hiv integrase inhibitors
07/02/2008EP1937655A1 Hiv-1 protease inhibitors, and methods of making and using them
07/02/2008EP1937651A1 Nnrt inhibitors
07/02/2008EP1937631A2 Hiv-1 protease inhibitors
07/02/2008EP1937308A1 Synthetic polyvalent carbohydrates as components of microbicides
07/02/2008EP1937284A1 Microbicidal dendrimer composition delivery system
07/02/2008EP1937272A2 Benzodiazepines as hcv inhibitors
07/02/2008EP1937257A1 Novel antibiotics comprising bis(1-aryl-5-tetraz0lyl)methane derivatives
07/02/2008EP1937256A2 Antiviral therapy with carbohydrate binding agents
07/02/2008EP1937235A2 Methods for treating viral infections using polyamine analogs
07/02/2008EP1937228A1 Pharmaceutical composition based on a morpholinic antimycotic agent and a water-soluble film-forming agent for ungual and periungual application
07/02/2008EP1596859B1 Treatment of diseases caused by ljungan virus by using pleconaril
07/02/2008EP1509519B1 Crystalline fluoroquinolone arginine salt form
07/02/2008EP1487791B1 A novel antifungal molecule 2-(3,4-dimethyl-2,5-dihydro-1h-pyrrol-2-yl)- methylethyl pentanoate
07/02/2008EP1474425B9 Deazapurines and uses thereof
07/02/2008EP1451181B1 Dimeric compounds and their use as anti-viral agents
07/02/2008EP1427436B1 Use of milk serum apoproteins in the prophylaxis or treatment of microbial or viral infection
07/02/2008EP1423385B1 Intermediates for preparing neuraminidase inhibitor conjugates
07/02/2008EP1265579B1 Container for linezolid intravenous solution
07/02/2008EP1165057B1 Endodontic fibers and methods of use therefor
07/02/2008EP1115720B1 Novel n-(iminomethyl)amine derivatives, their preparation, their use as medicines and compositions containing them
07/02/2008EP0667912B1 Defective adenovirus vectors and use thereof in gene therapy